全文获取类型
收费全文 | 4329篇 |
免费 | 368篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 114篇 |
妇产科学 | 132篇 |
基础医学 | 621篇 |
口腔科学 | 71篇 |
临床医学 | 807篇 |
内科学 | 786篇 |
皮肤病学 | 38篇 |
神经病学 | 324篇 |
特种医学 | 143篇 |
外科学 | 441篇 |
综合类 | 94篇 |
一般理论 | 8篇 |
预防医学 | 443篇 |
眼科学 | 92篇 |
药学 | 241篇 |
肿瘤学 | 337篇 |
出版年
2023年 | 26篇 |
2021年 | 61篇 |
2020年 | 26篇 |
2019年 | 65篇 |
2018年 | 85篇 |
2017年 | 67篇 |
2016年 | 68篇 |
2015年 | 65篇 |
2014年 | 86篇 |
2013年 | 199篇 |
2012年 | 255篇 |
2011年 | 246篇 |
2010年 | 140篇 |
2009年 | 133篇 |
2008年 | 225篇 |
2007年 | 249篇 |
2006年 | 286篇 |
2005年 | 289篇 |
2004年 | 242篇 |
2003年 | 253篇 |
2002年 | 217篇 |
2001年 | 96篇 |
2000年 | 92篇 |
1999年 | 76篇 |
1998年 | 68篇 |
1997年 | 45篇 |
1996年 | 45篇 |
1995年 | 42篇 |
1994年 | 35篇 |
1993年 | 36篇 |
1992年 | 78篇 |
1991年 | 59篇 |
1990年 | 56篇 |
1989年 | 39篇 |
1988年 | 52篇 |
1987年 | 53篇 |
1986年 | 43篇 |
1985年 | 56篇 |
1984年 | 37篇 |
1983年 | 23篇 |
1982年 | 39篇 |
1981年 | 32篇 |
1980年 | 34篇 |
1979年 | 18篇 |
1978年 | 29篇 |
1977年 | 32篇 |
1976年 | 16篇 |
1974年 | 16篇 |
1973年 | 18篇 |
1972年 | 22篇 |
排序方式: 共有4708条查询结果,搜索用时 171 毫秒
1.
Lois Isaksen MD 《Academic emergency medicine》2015,22(9):1125-1126
2.
3.
Coronary artery bypass grafts: visualization with MR imaging 总被引:1,自引:0,他引:1
4.
Lois J.Pround 《中华内分泌代谢杂志》2006,22(4):i0011-i0012
血糖仪的调码是指不同批号的试纸由于生产条件的不同而产生的批间差异,因此,在使用不同批号的试纸测试血糖时,需要血糖仪根据试纸上的密码校准批间差异。目前市场上的血糖仪大多在更换试纸时必须先手动调整血糖仪的代码或手动插入试纸盒内专用的代码卡。 相似文献
5.
David G Hicks Brian J Yoder Sarah Short Shannon Tarr Nichole Prescott Joseph P Crowe Andrea E Dawson G Thomas Budd Steven Sizemore Muzaffer Cicek Toni K Choueiri Raymond R Tubbs Daniel Gaile Norma Nowak Mary Ann Accavitti-Loper Andra R Frost Danny R Welch Graham Casey 《Clinical cancer research》2006,12(22):6702-6708
PURPOSE: This study aims to determine the effect of loss of breast cancer metastasis suppressor 1 (BRMS1) protein expression on disease-free survival in breast cancer patients stratified by estrogen receptor (ER), progesterone receptor (PR), or HER2 status, and to determine whether loss of BRMS1 protein expression correlated with genomic copy number changes. EXPERIMENTAL DESIGN: A tissue microarray immunohistochemical analysis was done on tumors of 238 newly diagnosed breast cancer patients who underwent surgery at the Cleveland Clinic between January 1, 1995 and December 31, 1996, and a comparison was made with 5-year clinical follow-up data. Genomic copy number changes were determined by array-based comparative genomic hybridization in 47 breast cancer cases from this population and compared with BRMS1 staining. RESULTS: BRMS1 protein expression was lost in nearly 25% of cases. Patients with tumors that were PR negative (P=0.006) or HER2 positive (P=0.039) and <50 years old at diagnosis (P=0.02) were more likely to be BRMS1 negative. No overall correlation between BRMS1 staining and disease-free survival was observed. A significant correlation, however, was seen between loss of BRMS1 protein expression and reduced disease-free survival when stratified by either loss of ER (P=0.008) or PR (P=0.029) or HER2 overexpression (P=0.026). Overall, there was poor correlation between BRMS1 protein staining and copy number status. CONCLUSIONS: These data suggest a mechanistic relationship between BRMS1 expression, hormone receptor status, and HER2 growth factor. BRMS1 staining could potentially be used in patient stratification in conjunction with other prognostic markers. Further, mechanisms other than genomic deletion account for loss of BRMS1 gene expression in breast tumors. 相似文献
6.
D H Russell N E Zorn A R Buckley P D Crowe M D Sauro E M Hadden R V Farese H E Laird 《European journal of pharmacology》1990,188(2-3):139-152
Prolactin (PRL) and other trophic factors rapidly activate a nuclear pool(s) of protein kinase C (nPKC) in purified splenocyte nuclei. The PRL also enhanced [2-3H]glycerol incorporation into nuclear mono- and triacylglycerol. An assay was devised which not only probed the ability of the hormone to activate protein kinase C (PKC) but also demonstrated the presence of nuclear substrates. Using this methodology, a biphasic concentration-response curve to PRL was observed. Heterologous species of PRL and various growth factors also activated nPKC. The PRL-induced nPKC stimulation was antagonized by various immunomodulators, G protein-coupling inhibitors, PKC inhibitors, a calmodulin inhibitor, and a peripheral benzodiazepine agonist and antagonist. A monoclonal antibody to PKC, anti-rat PRL antiserum and a monoclonal anti-rat PRL receptor antibody antagonized PRL-induced PKC-dependent nuclear phosphorylation, further implicating nPKC and a PRL receptor-mediated activation process. Nuclear PKC may be a major target for trophic regulation in response to both positive and negative growth signals. 相似文献
7.
Although the vulnerability of patients with sickle cell disease to infection with encapsulated organisms is well recognized, nosocomial transmission of infection has not been studied in this population. We describe eight serious, nosocomially transmitted infections in four adult patients hospitalized for complications of sickle cell disease, which led to death in one patient and prolonged hospital stays in three others. Although we have not surveyed all patients with sickle cell disease for rates of nosocomial infection, the cases presented suggest that these patients may be at increased risk. Risk can be reduced if health care workers are especially vigilant in adhering to handwashing and other infection control measures when caring for these patients. Additionally, we recommend that a patient with sickle cell disease not share a room with a patient known to have or suspected of having a nosocomial or community-acquired infectious disease. 相似文献
8.
腕管综合征主要症状体征敏感性与特异性的比较 总被引:5,自引:1,他引:4
目的 比较腕管综合征 (carpaltunnelsyndrome ,CTS)主要症状、体征的敏感性与特异性。方法 对 10 1例 ( 162只手 )进行症状严重程度与功能状况的询问 ,感觉、运动功能的检查 ;其中 62只手在术后 6周再次测定。结果 162只患手中 15 8只具有典型症状 ( 98% )。Phalen征、前臂正中神经加压征、Semmes Weinstein单丝纤维测试阳性率分别为 98%、96%、82 %。 87%的患手出现肌力下降 ,拇短展肌肌力测定 (定量法 )结果显示 ,与徒手法相比 ,不同性别间、术前与术后的差异均具非常显著意义 (P <0 .0 1)。结论 典型症状、Phalen征、前臂正中神经加压征、拇短展肌肌力变化的敏感性与特异性最高 ,拇短展肌肌力定量法测定是判断腕管综合征严重程度、评定疗效的一个良好的客观指标。 相似文献
9.
10.
Nina Singh Cheryl Wannstedt Lois Keyes Marilyn M Wagener Thomas V Cacciarelli 《Liver transplantation》2005,11(6):700-704
A vast majority of the transplant recipients are cytomegalovirus (CMV)-seropositive (R+). We sought to assess variables predictive of CMV infection, specifically in R+ liver transplant recipients. Study patients comprised 182 consecutive liver transplant recipients who survived at least 14 days after transplantation. Surveillance testing was used to detect CMV infection. Pre-emptive therapy was employed for the prevention of CMV disease, however, no antiviral prophylaxis was used for CMV infection. CMV infection developed in 32.5% (38 of 117) of R+ patients, 84.6% (33 of 39) of R-/D+, and 3.8% (1 of 26) of R-/D- patients. In R+ patients, Hispanic race (21.6% vs. 7.8%, P = 0.06), donor CMV seropositivity (73.7% vs. 45.6%, P = 0.005), and hepatocellular carcinoma (23.7% vs. 6.3%, P = 0.05) correlated with a higher risk of CMV infection. In a multivariate model, Hispanic race (OR: 3.5, 95% CI: 1.03-11.6, P = 0.045), donor CMV serostatus (OR: 4.0, 95% CI: 1.6-10.2, P = 0.003) and hepatocellular carcinoma (OR: 5.8, 95% CI: 1.6-20.5, P = 0.006) were all significant independent predictors of CMV infection. The aforementioned variables did not portend a higher risk of CMV infection in R-/D+ patients; donor CMV seropositivity overwhelmed all other risk factors in R- patients (P < 0.00001). In conclusion, CMV-seropositive liver transplant recipients at risk for CMV infection can be identified based on readily assessable variables. Preventive strategies may be selectively targeted toward these patients. 相似文献